Inocras
PrivateLast Round
Series B
Extension
Aug 3, 2026
Total Funding Raised
$89M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Inocras is a biotechnology company that provides an AI-driven platform offering whole genome insights to enable personalized care in cancer and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inocras Comparables
Compare Inocras with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Predicine | 84% | |
| Variantyx | 83% | |
| Strata Oncology | 79% | |
Inocras Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 3, 2026 | ||||
| Strategic | Jul 1, 2026 | ||||
| Series B Extension | Nov 1, 2023 | ||||
| Series B | Apr 30, 2022 | ||||
| Series A | Dec 1, 2020 | ||||
Series A | Nov 1, 2020 |
Key People
Founding team and executive leadership
Inocras Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Woori Investment & Securities | Series B Extension |
| InterVest | Series B Extension, Series B |
| DSC Investment | Series A, Series B Extension, Series B, Seed |
| Korea Investment & Securities | Series B Extension |
| Paratus Investment | Series A, Series B |
| Samsung Venture Investment | Series B Extension |
| Schmidt | Series A, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
$31M round with participation from Dt& Investment and DSC Investment.
- Jul 1, 2026
Raised a strategic round with Aimed Bio Inc.
Inocras Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inocras's valuation, stock price, and market status.